The article entitled, “Evaluation of Blood Glucose Meter Efficacy in an Antenatal Diabetes Clinic,” 2016;18(2):68–74. DOI: 10.1089/dia.2015.0104, is being officially retracted from Diabetes Technology and Therapeutics (DTT).
One year after the publication of this article, the lead author, Dr. Rachel T. McGrath (Royal North Shore Hospital; Sydney, Australia), contacted the Editor-in-Chief of DTT to ask for a significant number of corrections be made to the published text due to erroneous analyses of the data. After reviewing the pervasive nature of the requested changes, the Editor determined that the corrections do not qualify as errata, but instead warrants a full retraction.
While the errors in the reported analyses were unintentional, DTT and its editorial leadership are committed to maintaining the highest level of scientific reporting and publishing, and therefore officially retracts the article.
Get full access to this article
View all access options for this article.
References
1.
The Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) Study Cooperative Research Group, MetzgerBE, LoweLP, et al.: Hyperglycemia and adverse pregnancy outcomes. N Engl J Med, 2008; 358:1991–2002.
2.
CatalanoPM, McIntyreHD, CruickshankJK, et al.: The Hyperglycemia and Adverse Pregnancy Outcome Study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care, 2012; 35:780–786.
3.
MetzgerBE, BuchananTA, CoustanDR, et al.: Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care, 2007; 30(Suppl 2):S251–S260.
4.
HeerwagenMJ, MillerMR, BarbourLA, et al.: Maternal obesity and fetal metabolic programming: a fertile epigenetic soil. Am J Physiol Regul Integr Comp Physiol, 2010; 299:R711–R722.
5.
DalfraMG, SartoreG, Di CianniG, et al.: Glucose variability in diabetic pregnancy. Diabetes Technol Ther, 2011; 13:853–859.
6.
CrowtherCA, HillerJE, MossJR, et al.: Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med, 2005; 352:2477–2486.
ShawJE, SicreeRA, ZimmetPZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract, 2010; 87:4–14.
9.
WildS, RoglicG, GreenA, et al.: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004; 27:1047–1053.
10.
International Diabetes Federation: Gestational Diabetes. 2014. www.idf.org/gestational-diabetes (accessed March20, 2015).
11.
International Association of Diabetes, MetzgerBE, GabbeSG, et al.: International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care, 2010; 33:676–682.
12.
McLeanM, MoavenLD, MoinN, et al.: Controversy grows over redefinition of gestational diabetes. Med J Aust, 2012; 198:596–597.
13.
International Organization for Standardization: ISO 15197:2013: In Vitro Diagnostic Test Systems—Requirements for Blood-Glucose Monitoring Systems for Self-Testing in Managing Diabetes Mellitus. 2013. www.iso.org/iso/catalogue_detail?csnumber=54976 (accessed November11, 2014).
14.
MusholtPB, SchipperC, ThoméN, et al.: Dynamic electrochemistry corrects for hematocrit interference on blood glucose determinations with patient self-measurement devices. J Diabetes Sci Technol, 2011; 5:1167–1175.
15.
RamljakS, LockJP, SchipperCet al.: Hematocrit interference of blood glucose meters for patient self-measurement. J Diabetes Sci Technol, 2013; 7:179–189.
16.
ParwaizM, LuntH, FlorkowskiCM, et al.: Assessment of glucose meter performance at the antenatal diabetes clinic: exploration of patient-related and pre-analytical factors. Ann Clin Biochem, 2014; 51:47–53.
17.
PereraNJ, MolyneauxL, ConstantinoMI, et al.: Suboptimal performance of blood glucose meters in an antenatal diabetes clinic. Diabetes Care, 2011; 34:335–337.
18.
HoffmanL, NolanC, WilsonJD, et al.: Gestational diabetes mellitus—management guidelines. The Australasian Diabetes in Pregnancy Society. Med J Aust, 1998; 169:93–97.
19.
TeedeHJ, HarrisonCL, TehWT, et al.: Gestational diabetes: development of an early risk prediction tool to facilitate opportunities for prevention. Aust N Z J Obstet Gynaecol, 2011; 51:499–504.
20.
FreckmannG, BaumstarkA, SchmidC, et al.: Evaluation of 12 blood glucose monitoring systems for self-testing: system accuracy and measurement reproducibility. Diabetes Technol Ther, 2014; 16; 113–122.
21.
AlvaS: FreeStyle Lite—a blood glucose meter that requires no coding. J Diabetes Sci Technol, 2008; 2:546–551.
ClarkeWL, CoxD, Gonder-FrederickLA, et al.: Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care, 1987; 10:622–628.
24.
International Organization for Standardization: ISO 15197:2003: In Vitro Diagnostic Test Systems—Requirements for Blood-Glucose Monitoring Systems for Self-Testing in Managing Diabetes Mellitus. 2003. www.iso.org/iso/catalogue_detail?csnumber=26309 (accessed November11, 2014).
25.
NegratoCA, ZajdenvergL: Self-monitoring of blood glucose during pregnancy: indications and limitations. Diabetol Metab Syndr, 2012; 4; 54.
